Inventor
TAZI JAMAL
FR38 patents
⚠️ This page may combine multiple inventors who share the name “TAZI JAMAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABIVAX
27 patentsUS9637475B2May 2, 2017
Compounds for treating cancer
ABIVAX13 citations91
US10981874B2Apr 20, 2021
Use of quinoline derivatives for the treatment of inflammatory diseases
ABIVAX5 citations84
US10683284B2Jun 16, 2020
Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging
ABIVAX7 citations83
US10017498B2Jul 10, 2018
Compounds useful for treating AIDS
ABIVAX9 citations83
US9969715B2May 15, 2018
Compounds useful for treating cancer
ABIVAX5 citations83
US10253020B2Apr 9, 2019
Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
ABIVAX8 citations82
US9827237B2Nov 28, 2017
Compounds useful for treating diseases caused by retroviruses
ABIVAX10 citations82
US10435370B2Oct 8, 2019
Quinoline derivatives for the treatment of inflammatory diseases
ABIVAX11 citations81
US10717724B2Jul 21, 2020
Compounds useful for treating cancer
ABIVAX1 citations72
US11649211B2May 16, 2023
Use of quinoline derivatives for the treatment of inflammatory diseases
ABIVAX1 citations70
US10718770B2Jul 21, 2020
Methods for screening compounds for treating or preventing a viral infection or a virus-related condition
ABIVAX4 citations70
US12202804B2Jan 21, 2025
In vitro or ex vivo methods for screening a quinoline derivative
ABIVAX0 citations62
US11649210B2May 16, 2023
Use of quinoline derivatives for the treatment of inflammatory diseases
ABIVAX0 citations62
US11014918B2May 25, 2021
Compounds and pharmaceutical compositions containing at least one of the compounds
ABIVAX0 citations62
US10975063B2Apr 13, 2021
Compound, and production method thereof, and methods of treatment using the compound
ABIVAX0 citations62
US11441181B2Sep 13, 2022
miRNA-124 as a biomarker
ABIVAX1 citations61
US11427566B2Aug 30, 2022
Compounds useful for treating cancer
ABIVAX0 citations61
US12479802B2Nov 25, 2025
Phenyl-n-quinoline derivatives for treating a RNA virus infection
ABIVAX0 citations60
US12421206B2Sep 23, 2025
Aryl-n-aryl derivatives for treating a RNA virus infection
ABIVAX0 citations60
US12247018B2Mar 11, 2025
Aryl-n-aryl derivatives for treating a RNA virus infection
ABIVAX0 citations60
US12084422B2Sep 10, 2024
Phenyl-n-quinoline derivatives for treating a RNA virus infection
ABIVAX1 citations60
US11739073B2Aug 29, 2023
Aryl-n-aryl derivatives for treating a RNA virus infection
ABIVAX0 citations60
US10329317B2Jun 25, 2019
Quinoline derivative for use in the treatment and prevention of viral infections
ABIVAX1 citations59
US11992499B2May 28, 2024
Quinoline derivatives for use in the treatment of inflammation diseases
ABIVAX0 citations52
US10538485B2Jan 21, 2020
Compounds for use as therapeutic agents affecting P53 expression and/or activity
ABIVAX0 citations52
US9556489B2Jan 31, 2017
Use of RBM39 as a biomaker
ABIVAX0 citations46
US10806729B2Oct 20, 2020
Quinoline derivatives for use in the treatment or prevention of viral infection
ABIVAX0 citations39
TAZI JAMAL
3 patentsUS9145367B2Sep 29, 2015
Compounds useful for treating AIDS
TAZI JAMAL51 citations95
US9061999B2Jun 23, 2015
Compounds useful for treating AIDS
TAZI JAMAL17 citations82
US8604063B2Dec 10, 2013
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
TAZI JAMAL5 citations82
CENTRE NAT RECH SCIENT
3 patentsUS9233931B2Jan 12, 2016
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
CENTRE NAT RECH SCIENT5 citations83
US10654813B2May 19, 2020
Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
CENTRE NAT RECH SCIENT0 citations51
US7989467B2Aug 2, 2011
Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
CENTRE NAT RECH SCIENT1 citations45